BNIKF - Benitec, Incorporated Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BNIKF - Benitec, Incorporated

BNIKF 0.0162

0.0%

Apr 28 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: donpat	12/31/2005 12:22:52 PM
	Read Replies (1) of 8

J.P. Morgan Chase in London following the work of Benitec [Snip] Attracted by the huge potential of biotech stocks, many managers of diversified funds have increased their holdings. Ian Henderson, an investment manager with J.P. Morgan Chase in London, said he had been following the work of Benitec, "a tiny, thoroughly speculative company" that is developing therapies to treat diseases like AIDS and certain cancers. The aim of the therapy, called RNA interference, is to shut down the genes that cause the diseases. Scientists have had success with plants and animals; now they are working on Phase 1 clinical tests for the treatment of human diseases. iht.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next